$SSKN
STRATA Skin Sciences, Inc.

2019 Form 10-K Financial Statement

#000105151420000015 Filed on March 17, 2020

View on sec.gov

Income Statement

Concept 2019 2018 Q4 2018
Revenue $31.59M $7.960M $29.86M
YoY Change 5.8% -4.21% -6.01%
Cost Of Revenue $11.32M $2.890M $12.74M
YoY Change -11.14% -24.35% -2.02%
Gross Profit $20.27M $5.070M $17.12M
YoY Change 18.4% 12.92% -8.77%
Gross Profit Margin 64.17% 63.69% 57.34%
Selling, General & Admin $22.28M $5.350M $19.41M
YoY Change 14.78% 8.3% 2.95%
% of Gross Profit 109.91% 105.52% 113.38%
Research & Development $1.002M $230.0K $1.065M
YoY Change -5.92% -42.5% -37.76%
% of Gross Profit 4.94% 4.54% 6.22%
Depreciation & Amortization $2.693M $1.260M $3.563M
YoY Change -24.42% -17.65% -17.92%
% of Gross Profit 13.29% 24.85% 20.81%
Operating Expenses $23.28M $5.590M $20.48M
YoY Change 13.7% 4.68% -0.43%
Operating Profit -$3.010M -$520.0K -$3.355M
YoY Change -10.28% -38.82% 86.49%
Interest Expense $515.0K -$110.0K $1.142M
YoY Change -54.9% -102.32% -64.27%
% of Operating Profit
Other Income/Expense, Net -$929.0K $200.0K -$942.0K
YoY Change -1.38% 1900.0% -95.19%
Pretax Income -$3.939M -$430.0K -$4.297M
YoY Change -8.33% -90.36% -79.91%
Income Tax -$149.0K -$260.0K -$264.0K
% Of Pretax Income
Net Earnings -$3.790M -$170.0K -$4.033M
YoY Change -6.03% -96.14% -81.25%
Net Earnings / Revenue -12.0% -2.14% -13.51%
Basic Earnings Per Share -$0.11 -$0.15
Diluted Earnings Per Share -$0.11 -$5.655K -$0.15
COMMON SHARES
Basic Shares Outstanding 31.98M 19.59M
Diluted Shares Outstanding 31.98M 19.59M

Balance Sheet

Concept 2019 2018 Q4 2018
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.130M $16.49M $16.49M
YoY Change -50.7% 305.16% 305.16%
Cash & Equivalents $8.130M $16.49M $16.49M
Short-Term Investments
Other Short-Term Assets $8.010M $540.0K $540.0K
YoY Change 1383.33% 1.89% 1.89%
Inventory $3.030M $2.794M $2.790M
Prepaid Expenses
Receivables $4.390M $3.393M $3.390M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $23.56M $23.21M $23.21M
YoY Change 1.51% 115.87% 115.91%
LONG-TERM ASSETS
Property, Plant & Equipment $6.680M $5.301M $5.300M
YoY Change 26.04% -31.18% -31.17%
Goodwill $8.803M
YoY Change 0.0%
Intangibles $9.765M
YoY Change -17.42%
Long-Term Investments
YoY Change
Other Assets $350.0K $428.0K $430.0K
YoY Change -18.6% 791.67% 760.0%
Total Long-Term Assets $23.78M $24.30M $24.30M
YoY Change -2.14% -14.38% -14.38%
TOTAL ASSETS
Total Short-Term Assets $23.56M $23.21M $23.21M
Total Long-Term Assets $23.78M $24.30M $24.30M
Total Assets $47.34M $47.51M $47.51M
YoY Change -0.36% 21.41% 21.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.880M $1.764M $1.760M
YoY Change 6.82% -22.53% -22.81%
Accrued Expenses $5.450M $4.500M $4.500M
YoY Change 21.11% 25.66% 28.57%
Deferred Revenue $2.099M
YoY Change 12.19%
Short-Term Debt $7.280M $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $0.00 $252.0K $250.0K
YoY Change -100.0% -89.44% -89.54%
Total Short-Term Liabilities $17.43M $8.615M $8.620M
YoY Change 102.2% -17.74% -17.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $7.145M $7.150M
YoY Change -100.0% -9.02% -8.92%
Other Long-Term Liabilities $1.260M $388.0K $390.0K
YoY Change 223.08% -12.61% -23.53%
Total Long-Term Liabilities $1.260M $7.533M $7.540M
YoY Change -83.29% -9.21% -9.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.43M $8.615M $8.620M
Total Long-Term Liabilities $1.260M $7.533M $7.540M
Total Liabilities $18.69M $16.26M $16.26M
YoY Change 14.94% -15.54% -15.53%
SHAREHOLDERS EQUITY
Retained Earnings -$210.8M
YoY Change 3.34%
Common Stock $30.00K
YoY Change 650.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $28.65M $31.25M $31.25M
YoY Change
Total Liabilities & Shareholders Equity $47.34M $47.51M $47.51M
YoY Change -0.36% 21.41% 21.42%

Cashflow Statement

Concept 2019 2018 Q4 2018
OPERATING ACTIVITIES
Net Income -$3.790M -$170.0K -$4.033M
YoY Change -6.03% -96.14% -81.25%
Depreciation, Depletion And Amortization $2.693M $1.260M $3.563M
YoY Change -24.42% -17.65% -17.92%
Cash From Operating Activities $2.229M $1.100M $2.896M
YoY Change -23.03% -41.8% -30.05%
INVESTING ACTIVITIES
Capital Expenditures $115.0K -$500.0K -$1.760M
YoY Change -106.53% 72.41% -14.56%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$20.00K
YoY Change -100.0% -100.0% -85.71%
Cash From Investing Activities -$2.791M -$510.0K -$1.785M
YoY Change 56.36% 70.0% -18.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $17.00M
YoY Change -100.0%
Debt Paid & Issued, Net $7.571M $3.000M
YoY Change 152.37% 109.94%
Cash From Financing Activities -296.0K 0.000 11.31M
YoY Change -102.62% -100.0% -727.12%
NET CHANGE
Cash From Operating Activities 2.229M 1.100M 2.896M
Cash From Investing Activities -2.791M -510.0K -1.785M
Cash From Financing Activities -296.0K 0.000 11.31M
Net Change In Cash -858.0K 590.0K 12.42M
YoY Change -106.91% -37.89% 8707.09%
FREE CASH FLOW
Cash From Operating Activities $2.229M $1.100M $2.896M
Capital Expenditures $115.0K -$500.0K -$1.760M
Free Cash Flow $2.114M $1.600M $4.656M
YoY Change -54.6% -26.61% -24.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019Q2 dei Entity Public Float
EntityPublicFloat
49145678
CY2019 dei Entity Registrant Name
EntityRegistrantName
STRATA Skin Sciences, Inc.
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001051514
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33714362
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Type
DocumentType
10-K
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16487000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8129000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-858000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12418000
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
749901
CY2018Q4 us-gaap Assets
Assets
47507000
CY2019Q4 us-gaap Assets
Assets
47343000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
23210000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
23555000
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1880000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1764000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4386000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3393000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4500000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5134000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13532000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15962000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
243180000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
241988000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
904000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1195000
CY2019 us-gaap Advertising Expense
AdvertisingExpense
1936000
CY2018 us-gaap Advertising Expense
AdvertisingExpense
1202000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
141000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
184000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1834000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1810000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5665131
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5881396
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4069000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16487000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15629000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
155000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2832000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2099000
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
11316000
CY2018 us-gaap Cost Of Revenue
CostOfRevenue
12735000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
39000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-38000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
39000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29943086
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32932273
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32932273
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29943086
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
33000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
30000
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; text-indent: 0.55pt; font-family: 'Times New Roman', Times, serif; font-style: italic; font-weight: bold;">Concentration of Credit Risks</div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif;">Financial instruments which subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash and accounts receivable. The Company deposits cash and cash equivalents and restricted cash in major financial institutions in the US which, at times exceeds Federal Deposit Insurance Corporation and Securities Investor Protection Corporation limits. The Company performs periodic evaluations of the relative credit standing of these institutions. The Company is of the opinion that the credit risk in respect of these balances is immaterial. In addition, the Company performs periodic credit evaluation and establishes an allowance for doubtful accounts based upon factors surrounding the credit risk of customers. (See also <font style="font-weight: bold; font-style: italic;">Accounts receivable</font> above).</div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif;">&#160;</div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif;">With the exception of the Company&#8217;s international distributor, as described in <font style="font-style: italic;">Note 18</font>, <font style="font-weight: bold;">Significant Customer</font>&#160;<font style="font-weight: bold;">Concentrations</font>, the balance of the Company&#8217;s trade receivables does not represent a substantial concentration of credit risk. Most of the Company&#8217;s sales are generated in North America, to a large number of customers.</div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif;">&#160;</div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif;">Management periodically evaluates the collectability of the trade receivables to determine the amounts that are doubtful of collection and determine a proper allowance for doubtful accounts.</div></div>
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
267000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
115000
CY2018 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
58000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
20000
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-58000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
111000
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
389000
CY2019 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-111000
CY2018 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-303000
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-282000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-86000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-303000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-111000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
47113000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
46595000
CY2019Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
51000
CY2018Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
50000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-25000
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-21000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
43433000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
42283000
CY2018Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
111000
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
884000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1011000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
620000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
850000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
47113000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
46706000
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
64000
CY2018Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
518000
CY2019Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
667000
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
35000
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
248000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4503000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5397000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2693000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3563000
CY2018Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2726000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1275000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1193000
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
0
CY2018 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
0
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
16100000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9765000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7955000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
705000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-6335000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-8145000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1610000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1410000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1410000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1410000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1410000
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-407000
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-414000
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10275000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8786000
CY2019 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-style: italic; font-weight: bold;">Reclassification</div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif;">Certain reclassifications from the prior year presentation have been made to conform to the current year presentation.</div></div>
CY2019 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
7275000
CY2018 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-357000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2018Q4 us-gaap Goodwill
Goodwill
8803000
CY2019Q4 us-gaap Goodwill
Goodwill
8803000
CY2019Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2018Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2019 us-gaap Gross Profit
GrossProfit
20270000
CY2018 us-gaap Gross Profit
GrossProfit
17120000
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
-194000
CY2019 us-gaap Income Tax Examination Estimate Of Possible Loss
IncomeTaxExaminationEstimateOfPossibleLoss
801000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4297000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3939000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-264000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-149000
CY2019Q4 us-gaap Income Tax Examination Interest Accrued
IncomeTaxExaminationInterestAccrued
171000
CY2019Q4 us-gaap Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority
IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority
724000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-827000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-902000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
407000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-172000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-106000
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
688000
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
225000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
377000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
79000
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
17000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
733000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
171000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-513000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
116000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
222000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1036000
CY2018 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1006000
CY2019 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
634000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-215000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
233000
CY2018 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-60000
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-210000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
383000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-104000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9765000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7955000
CY2018 us-gaap Interest Expense
InterestExpense
1142000
CY2019 us-gaap Interest Expense
InterestExpense
515000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
1009000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
766000
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
352000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
376000
CY2018Q4 us-gaap Liabilities
Liabilities
16259000
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
308000
CY2019Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
2651000
CY2018Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
2442000
CY2018Q4 us-gaap Inventory Net
InventoryNet
2794000
CY2019Q4 us-gaap Inventory Net
InventoryNet
3027000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
436000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
242000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
186000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1691000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
300000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
371000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
456000
CY2019Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P36M
CY2018 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
440000
CY2019Q4 us-gaap Liabilities
Liabilities
18690000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47343000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47507000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8615000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17434000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7145000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
252000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2018Q4 us-gaap Noncurrent Assets
NoncurrentAssets
47507000
CY2019Q4 us-gaap Noncurrent Assets
NoncurrentAssets
47343000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2229000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2896000
CY2019Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
62000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18833000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21331000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
428000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
347000
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
170000
CY2019 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
228000
CY2018 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
231000
CY2018Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
238000
CY2017Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
178000
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17000000
CY2018Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
156000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1785000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2791000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11307000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-296000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-4033000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-3790000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2909000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3597000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-942000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-929000
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2019 us-gaap Open Tax Year
OpenTaxYear
2016
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1314000
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
448000
CY2019 us-gaap Operating Expenses
OperatingExpenses
23280000
CY2018 us-gaap Operating Expenses
OperatingExpenses
20475000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-3355000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-3010000
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
313000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1078000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
371000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1391000
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
191920000
CY2019Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
191920000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
200000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
178000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
388000
CY2019 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
115000
CY2018 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
13000
CY2019 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2018 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2336000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
536000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
513000
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
232000
CY2018 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
291000
CY2019 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
222000
CY2018Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
82000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5301000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5369000
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
43000
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-30000
CY2018 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3000000
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7571000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1002000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1065000
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
7500000
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-210771000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-214561000
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
324000
CY2018Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
429000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29855000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31586000
CY2019Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
1.90
CY2019Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
2.04
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y2M5D
CY2019 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P8Y0M11D
CY2018 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P5Y9M18D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2019 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P8Y6M
CY2018Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
2719000
CY2019Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3193000
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10624000
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12003000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
904000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
1195000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.71
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0166
CY2019Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
4908038
CY2019Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1904526
CY2018Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
153004
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14664000
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
19880000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
28653000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
31248000
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-style: italic; font-weight: bold;">Use of Estimates</div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting periods. Actual results could differ from those estimates and be based on events different from those assumptions. As of December 31, 2019, the more significant estimates include (1) revenue recognition, in regard to deferred revenues and the contract term and valuation allowances of accounts receivable, (2) the inputs used in the impairment analyses of goodwill, (3) the estimated useful lives of intangible assets and property and equipment, (4) the inputs used in determining the fair value of equity-based awards, (5) the valuation allowance related to deferred tax assets (6) the fair value of financial instruments, including derivative instruments and warrants, (7) the inventory reserves (8) state sales and use tax accruals and (9) warranty claims.</div></div>
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
407000
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-172000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31978665
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19589031
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31978665
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19589031
CY2019 sskn Net Income Loss Available To Preferred Stock
NetIncomeLossAvailableToPreferredStock
-193000
CY2018 sskn Net Income Loss Available To Preferred Stock
NetIncomeLossAvailableToPreferredStock
-1124000
CY2019 sskn Earnings Per Share Basic And Diluted Preferred Share
EarningsPerShareBasicAndDilutedPreferredShare
-42.24
CY2018 sskn Earnings Per Share Basic And Diluted Preferred Share
EarningsPerShareBasicAndDilutedPreferredShare
-55.20
CY2018 sskn Weighted Average Number Of Share Outstanding Basic And Diluted Preferred Stock
WeightedAverageNumberOfShareOutstandingBasicAndDilutedPreferredStock
20368
CY2019 sskn Weighted Average Number Of Share Outstanding Basic And Diluted Preferred Stock
WeightedAverageNumberOfShareOutstandingBasicAndDilutedPreferredStock
4577
CY2018 sskn Stock Issuance Costs
StockIssuanceCosts
2336000
CY2019 sskn Increase Decrease Of Lease Liabilities Arising From Obtaining Right Of Use Assets
IncreaseDecreaseOfLeaseLiabilitiesArisingFromObtainingRightOfUseAssets
1632000
CY2018 sskn Increase Decrease Of Lease Liabilities Arising From Obtaining Right Of Use Assets
IncreaseDecreaseOfLeaseLiabilitiesArisingFromObtainingRightOfUseAssets
0
CY2019 sskn Amortization Of Debt Issuance Costs And Debt Discount Premium
AmortizationOfDebtIssuanceCostsAndDebtDiscountPremium
174000
CY2018 sskn Amortization Of Debt Issuance Costs And Debt Discount Premium
AmortizationOfDebtIssuanceCostsAndDebtDiscountPremium
157000
CY2019 sskn Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
318000
CY2018 sskn Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
0
CY2018 sskn Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
0
CY2019 sskn Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-241000
CY2019 sskn Payments For Distributor Rights Liability
PaymentsForDistributorRightsLiability
0
CY2018 sskn Payments For Distributor Rights Liability
PaymentsForDistributorRightsLiability
23000
CY2018 sskn Payment For Lasers Placed In Service Net
PaymentForLasersPlacedInServiceNet
1749000
CY2019 sskn Payment For Lasers Placed In Service Net
PaymentForLasersPlacedInServiceNet
2676000
CY2019 sskn Gain Loss On Cancelation Of Distributor Rights Agreement
GainLossOnCancelationOfDistributorRightsAgreement
0
CY2018 sskn Gain Loss On Cancelation Of Distributor Rights Agreement
GainLossOnCancelationOfDistributorRightsAgreement
11000
CY2019 sskn Impairment Of Lasers Placed In Service
ImpairmentOfLasersPlacedInService
30000
CY2018 sskn Impairment Of Lasers Placed In Service
ImpairmentOfLasersPlacedInService
194000
CY2019 sskn Operating Lease Incremental Borrowing Rate Percent
OperatingLeaseIncrementalBorrowingRatePercent
0.0976
CY2018 sskn Conversion Of Convertible Preferred Stock Amount
ConversionOfConvertiblePreferredStockAmount
0
CY2019 sskn Conversion Of Convertible Preferred Stock Amount
ConversionOfConvertiblePreferredStockAmount
0
CY2019Q4 sskn Notes Payables Current
NotesPayablesCurrent
7275000
CY2018Q4 sskn Notes Payables Current
NotesPayablesCurrent
0
CY2019 sskn Income Tax Reconciliation Warrant Value Fluctuation
IncomeTaxReconciliationWarrantValueFluctuation
0
CY2018 sskn Income Tax Reconciliation Warrant Value Fluctuation
IncomeTaxReconciliationWarrantValueFluctuation
43000
CY2019Q4 sskn Deferred Tax Assets Intangible Assets
DeferredTaxAssetsIntangibleAssets
2046000
CY2018Q4 sskn Deferred Tax Assets Intangible Assets
DeferredTaxAssetsIntangibleAssets
3340000
CY2018 sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.573
CY2019 sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.642
CY2018 sskn Equity Financing Cost
EquityFinancingCost
2336000
CY2018Q1 sskn Stock Issued During Period Value New Issues Expected
StockIssuedDuringPeriodValueNewIssuesExpected
17000000
CY2018Q4 sskn Accrued Professional Fees Other Accrued Liabilities
AccruedProfessionalFeesOtherAccruedLiabilities
350000
CY2019Q4 sskn Accrued Professional Fees Other Accrued Liabilities
AccruedProfessionalFeesOtherAccruedLiabilities
578000
CY2019 sskn Lease Automatic Renewal Period
LeaseAutomaticRenewalPeriod
P1Y
CY2018 sskn Reclassification Of Reimbursements From Selling And Marketing Expenses To Revenues
ReclassificationOfReimbursementsFromSellingAndMarketingExpensesToRevenues
579000
CY2019 sskn Reclassification Of Reimbursements From Selling And Marketing Expenses To Revenues
ReclassificationOfReimbursementsFromSellingAndMarketingExpensesToRevenues
779000
CY2019 sskn Number Of Types Of Arrangements
NumberOfTypesOfArrangements
2
CY2019Q4 sskn Contract With Customer Liability Current Advance Consideration
ContractWithCustomerLiabilityCurrentAdvanceConsideration
209000
CY2018Q4 sskn Contract With Customer Liability Current Advance Consideration
ContractWithCustomerLiabilityCurrentAdvanceConsideration
162000
CY2019Q4 sskn Proceeds Due From Credit Card Transactions
ProceedsDueFromCreditCardTransactions
21000
CY2018Q4 sskn Proceeds Due From Credit Card Transactions
ProceedsDueFromCreditCardTransactions
6000

Files In Submission

Name View Source Status
0001051514-20-000015-index-headers.html Edgar Link pending
0001051514-20-000015-index.html Edgar Link pending
0001051514-20-000015.txt Edgar Link pending
0001051514-20-000015-xbrl.zip Edgar Link pending
ex_23-1.htm Edgar Link pending
ex_31-1.htm Edgar Link pending
ex_31-2.htm Edgar Link pending
ex_32-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form_10-k.htm Edgar Link pending
image00003.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sskn-20191231.xml Edgar Link completed
sskn-20191231.xsd Edgar Link pending
sskn-20191231_cal.xml Edgar Link unprocessable
sskn-20191231_def.xml Edgar Link unprocessable
sskn-20191231_lab.xml Edgar Link unprocessable
sskn-20191231_pre.xml Edgar Link unprocessable